Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma
- 1 August 2001
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 36 (8) , 1285-1292
- https://doi.org/10.1053/jpsu.2001.25796
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12Cancer Gene Therapy, 1999
- A comparative review of the immunobiology of murine neuroblastoma and human neuroblastomaCancer, 1997
- High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.The Journal of Experimental Medicine, 1996
- IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro.Journal of Clinical Investigation, 1996
- IL-12: a key cytokine in immune regulationImmunology Today, 1996
- Interleukin‐12 is produced by dendritic cells and mediates T helper 1 development as well as interferon‐γ production by T helper 1 cellsEuropean Journal of Immunology, 1996
- Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.The Journal of Experimental Medicine, 1996
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.The Journal of Experimental Medicine, 1989